Concerning the final report "Hyperthermia: A systematic review" of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010

Strahlentherapie und Onkologie

Volumn 188, Issue 3, 2012, Pages 209-215

  Sauer, R ^a   Creeze, H ^b   Hulshof, M ^b   Issels, R ^c   Ott, O ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; MITOMYCIN C;

AUSTRIA; BLADDER CANCER; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; EDITORIAL; HEALTH CARE ORGANIZATION; HUMAN; HYPERTHERMIA; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; RADIATION DOSE; RADIOSENSITIZATION; SOFT TISSUE SARCOMA; SYSTEMATIC REVIEW; TEMPERATURE SENSITIVITY; TOTAL QUALITY MANAGEMENT; UTERINE CERVIX CANCER;

ACADEMIES AND INSTITUTES; AUSTRIA; HUMANS; HYPERTHERMIA, INDUCED; NEOPLASMS; RESEARCH REPORT; REVIEW LITERATURE AS TOPIC;

EID: 84862668752     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0072-9     Document Type: Editorial

References (29)

1. GBA Gemeinsamer Bundesausschuss der Bundesrepublik Deutschland: Zusammenfassender Bericht des Unterausschusses ̈rztliche Behandlung" des Gemeinsamen Bundesausschusses über die Bewertung gemäß § 135 Abs. 1 SGB V der Hyperthermie (u. a. Ganzkörper-Hyperthermie, Regionale Tiefenhyperthermie, Oberflächen-Hyperthermie, Hyperthermie in Kombination mit Radiatio und/oder Chemotherapie) (2005), available at http://www.g-ba.de/downloads/40-268- 236/2005-06-15-BUB-Hyperthermie.pdf, accessed 27 January 2012
2. Mathis S, Johnasson T (2010) Hyperthermie. Decision Support Document 36 (2010); Ludwig Boltzmann Institut für Health Technology Assessment (LBI-HTA) ISSN-online: 1992-0496, available at http://eprints.hta.lbg.ac.at, accessed 27 January 2012
3. Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35:731-744 (Pubitemid 26251128)
4. Jones EL, Oleson JR, Prosnitz LR et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079-3085 (Pubitemid 46224131)
5. Jones EL, Marks LB, Prosnitz LR (2007) Point: hyperthermia with radiation for chest wall recurrences. J Natl Compr Canc Netw 5:339-344 (Pubitemid 46465555)
6. Van der Zee J, Rhoon GC van, Wijnmaalen AJ et al (1999) Reirradiatie met hyperthermie bij patiënten met een recidief mammacarcinoom. Ned Tijd Gen 143:80-84 (Pubitemid 29031141)
7. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer: Version 2.2011; available at http:// www.nccn.com, accessed 27 January 2012
8. Conceptrichtlijn mammacarcinoom 2011. Internet: Integraal Kankercentrum Nederland. http://www. oncoline.nl, accessed 27 January 2012
9. Chen HW, Jun-Jie F, Wei L (1997) A randomized trial of hyper-thermo-radiochemotherapy for uterine cervix cancer. Chin J Clin Oncol 24:249-251
10. Datta NR, Bose AK, Kapoor HK (1987) Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): a controlled clinical study. Ind Med Gaz 121:68-71
11. Harima Y, Nagata K, Harima K et al (2001) A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17:97-105 (Pubitemid 32185837)
12. Sharma S, Patel FD, Sandhu APS et al (1989) A prospective randomised study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol 5:151-159
13. Vasanthan A, Mitsumori M, Park JH et al (2005) Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 61:145-153 (Pubitemid 40039116)
14. Lutgens L, Zee J van der, Pijls-Johannesma M et al (2010) Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev DOI 10.1002/14651858.CD006377.pub3
15. Zee J van der, Gonzalez GD, Rhoon GC van et al (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119-1125 (Pubitemid 30172932)
16. Franckena M, Stalpers LJ, Koper PC et al (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176-1182 (Pubitemid 351296102)
17. Krause FS, Walter B, Ott OJ et al (2010) 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. Anticancer Res 31:985-990
18. Ott OJ, Rodel C, Weiss C et al (2009) Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol) 21:557-565
19. Rodel C, Grabenbauer GG, Kuhn R et al (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: longterm results. J Clin Oncol 20:3061-3071 (Pubitemid 34791095)
20. Wittlinger M, Rodel CM, Weiss C et al (2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 93:358-363
21. Colombo R, Da Pozzo LF, Salonia A et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21:4270-4276 (Pubitemid 46621801)
22. Issels R, Lindner LH, Verweij J et al (2010) for the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and the European Society for Hyperthermic Oncology (ESHO). Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561-570
23. NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma: Version 2.2011; available at http:// www.nccn.com, accessed 27 January 2012
24. Issels RD, Lindner LH, Wust P et al (2007) Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: a phase III randomised prospective trial (EORTC-ESHO Intergroup trial) [abstract 10009]. J Clin Oncol 25(Suppl 18):547
25. Bruggmoser G, Bauchowitz S, Canters R et al (2011) Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 187:605-610
26. Zagar TM et al (2010) Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: A review of the randomised data. Int J Hyperthermia 26(7):612-617
27. Overgaard J, Gonzalez Gonzalez D, Hulshof MC et al (1995) Randomized trial of hyperthermia as an adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345:540-543
28. Huilgol NG, Gupta S, Sridhar CR (2010) Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther 6(4):492-496
29. Valdagni R, Amichetti M (1993) Report of longterm follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28:163-169 (Pubitemid 24012868)